Drug Price Cut Paves Way in Global Fight Against Tuberculosis
The price of rifapentine, a lifesaving antibiotic that can prevent tuberculosis, was marked down by 66% by its manufacturer Sanofi, an announcement Gavin Churchyard for The Conversation Africa describes as good news. Talks to lower the price from U.S.$45 to U.S.$15 for a three-month course took more than a year to complete with an announcemnt eventually made during the Union World Conference on Lung Health in October 2019.
The cost of the drug, rifapentine, will be cut from U.S.$45 to $15 dollars for a recommended three-month course of treatment in 100 nations - including 48 in Africa - where TB is a ... Read more »
People with drug-resistant tuberculosis continue to be deprived of the best-possible treatment in part because of high drug prices, according to Doctors Without Borders. Read more »
"TB remains the world's deadliest infectious killer. Each day, nearly 4,500 people lose their lives to TB and close to 30,000 people fall ill with this preventable and curable ... Read more »
See What Everyone is Watching